Meetings Events & Conference Coordinators 19th Annual New Orleans Summer Cancer Meeting 2024

Meetings Events & Conference Coordinators 19th Annual New Orleans Summer Cancer Meeting 2024

• Oncologists
• Hematologists
• Radiation oncologists
• Surgical oncologists
• Medical oncologists
• Oncology nurses
• Pharmacists
• Researchers
• Other healthcare professionals involved in cancer care

• Acquired Inhibitors in Cancer- State-of-the Art Management.mp4
  Addressing Disparities in Access to Supportive Care During Cancer Treatment and Survivorship- An Integrative Approach.mp4
  ALK- First Line and Mechanism Of Resistance.mp4
  Antibody Drug Conjugates for HER2 Negative Breast Cancer- A Revolution in Chemotherapy for Breast Cancer.mp4
  Applying New Endocrine and Targeted Agents to the Treatment of Hormone Receptor Positive, HER2 Negative Breast Cancer.mp4
  Artificial Intelligence and Modern Medical Practice- Do’s and Don’ts.mp4
  Bladder Cancer- Novel Insights and Recent Approvals.mp4
  Cancer Care Disparities in Puerto Rico.mp4
  Cancer Genetic Risk Factors- What’s New and What You Need to Know..mp4
  CAR-T Cell Therapy in Lymphomas- 7-Years Later.mp4
  Challenges in Lung Cancer Pathology- Biomarkers.mp4
  CLL- Therapeutic Advances in 2024.mp4
  Colorectal Cancer- Novel Treatment Paradigms.mp4
  Controversies in Colon Cancer- ctDNA in the Adjuvant Therapy of Colon Cancer and in the Management of Oligometastases (Against).mp4
  Controversies in Colon Cancer- ctDNA in the Adjuvant Therapy of Colon Cancer and in the Management of Oligometastases (in Favor).mp4
  Controversy in Breast Cancer- Should be pCR Be an Acceptable Endpoint for Approval of New Therapies for Early-Stage Breast Cance.mp4
  Controversy in Breast Cancer- Should be pCR Be an Acceptable Endpoint for Approval of New Therapies for Early-Stage Breast Cance_2.mp4
  Cost and Access to Novel Therapeutic Agents. Where Are The Obstacles..mp4
  ctDNA in Lung Cancer- Current State and Future Perspectives.mp4
  De Novo Acute Myeloid Leukemia.mp4
  Diabetes Management in the Face of Healthcare Disparities.mp4
  EGFR Exon 20 Insertions- Novel Agents.mp4
  End of Life Management- Oncologists’ Perspectives.mp4
  Equity and Equality for Minorities in Cancer Care.mp4
  Immunotherapy for Breast Cancer- Efficacy and Toxicity Considerations.mp4
  K-RAS Therapies in NSCLC.mp4
  Kidney Cancer- Novel Development in Targeted and Immunotherapy.mp4
  Leveraging NCODA Resources to Manage Patients on Oral Oncolytics.mp4
  Lifestyle Modifications in Reducing Risk of Recurrence.mp4
  los-noscm-2024-flyer.pdf
  Lung Cancer With EGFR Exon 19 and L858R Mutations- The Optimal Front Line Therapy.mp4
  Malignant Hematology and Use of Bi-specifics in Puerto Rico.mp4
  Melanoma- Novel Advances in Immunotherapy.mp4
  Metastatic Castration Resistant Prostate Cancer- Sequencing the Treatment.mp4
  Navigating Mantle Cell Lymphoma in the Era of Targeted Therapy.mp4
  Neuro-Oncology- Novel Advances in Therapy.mp4
  Neurology Drug Update.mp4
  New and Evolving Directions in the Treatment of HER2 Positive Breast Cancer.mp4
  Non Driver NSCLC-The Immunotherapy Strategy.mp4
  Novel Advances for Thyroid Carcinoma and Thymoma.mp4
  Novel Advances in T-Cell NHL Therapies.mp4
  Obesity Management with Incretin Therapies- Considerations for Patients with and without Type 2 Diabetes.mp4
  Optimal Surgical Approach in Early Stages NSCLC.mp4
  Other Driver Mutations- ROS-1, BRAF, MET and RET.mp4
  Pancreas, Hepatic and Cholangiocarcinoma- Advances in 2024.mp4
  Pharmacology I- What HemOnc Clinicians Must Know in Immunotherapy.mp4
  Prostate Cancer- Early and Locally Advanced Disease.mp4
  Role of Pharmacist in Vaccination–Challenges and Opportunities.mp4
  Screening in Lung Cancer- Challenges and Obstacles.mp4
  Sequencing Therapy in Relapsed-Refractory Myeloma Patients.mp4
  Small Cell Lung Cancer- Targeting This Difficult Target.mp4
  Soft Tissue and Osteosarcomas- Novel Advances in 2024.mp4
  Targeted Therapy in Hema Malignancies (CD20, CD30, CD33, BCR-ABL, FLT3, IDH1-2).mp4
  Testicular Cancer- The Old, The New, The Future.mp4
  Upfront Treatment for Common Ovarian Cancer (High Grade Serous) Versus Rare Histologies– Focus on PARPi and Other Targeted Ther.mp4
  Upper GI Cancer- Esophageal and Gastric-New Developments.mp4
  What Is Next After Osimertinib Progression..mp4